by Eric Christianson | Aug 10, 2025 | Polypharmacy Cases And The Prescribing Cascade
Mrs. M is an 87-year-old female residing in a skilled nursing facility. Her medication list includes: Apixaban 5 mg BID (for atrial fibrillation) Docusate 100 mg BID Senna 8.6 mg BID PEG 17 g daily Calcium carbonate 500 mg TID Lisinopril 10 mg daily Metoprolol...
by Eric Christianson | Feb 12, 2025 | Cardiovascular Medication and Disease State Clinical Pearls
This video is part of a three-part series covering new literature that could influenceclinical practice. In this video, I discuss the combined usage of antiplatelets with DOACsin patients with ASCVD risk and atrial fibrillation. Each mechanism of action is reviewed,as...
by Eric Christianson | Apr 8, 2020 | Educational Case Studies For Pharmacists
One of the things I did most often when I started this blog nearly 7 years ago was snag a medication list and tell you what my top priorities are to investigate. I’m going to do a little throwback and go through one tonight with my top three priorities....
by Eric Christianson | Jan 19, 2020 | Clinical Pharmacy News and New Drug Updates
FDA Approval The FDA has recently approved two generic versions of apixaban and from the amount of apixaban I’m seeing used in clinical practice, this is a great thing for overall healthcare and drug costs. Here’s the FDA’s statement. Because of this...
by Eric Christianson | Jan 16, 2019 | Drug Interaction Case Studies and Education For Pharmacists
P-Glycoprotein inhibitors can and do affect the concentrations of other drugs. I will be honest in that when I think about drug interactions, it isn’t the first thing that comes to mind. This gut transporter can impact clinical care and influence drug decisions....
